These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37169499)
1. Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG). Berrih-Aknin S; Palace J; Meisel A; Claeys KG; Muppidi S; Saccà F; Amini F; Larkin M; Quinn C; Beauchamp J; Philips G; De Ruyck F; Ramirez J; Paci S BMJ Open; 2023 May; 13(5):e068104. PubMed ID: 37169499 [TBL] [Abstract][Full Text] [Related]
2. Patient-reportedimpact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG). Berrih-Aknin S; Claeys KG; Law N; Mantegazza R; Murai H; Saccà F; Dewilde S; Janssen MF; Bagshaw E; Kousoulakou H; Larkin M; Beauchamp J; Leighton T; Paci S BMJ Open; 2021 Jul; 11(7):e048198. PubMed ID: 34285010 [TBL] [Abstract][Full Text] [Related]
3. Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG. Dewilde S; Philips G; Paci S; Beauchamp J; Chiroli S; Quinn C; Day L; Larkin M; Palace J; Berrih-Aknin S; Claeys KG; Muppidi S; Mantegazza R; Saccà F; Meisel A; Bassez G; Murai H; Janssen MF BMJ Open; 2023 Jan; 13(1):e066445. PubMed ID: 36720569 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Mahic M; Bozorg A; DeCourcy J; Golden K; Gibson G; Taylor C; Scowcroft A Orphanet J Rare Dis; 2023 Jun; 18(1):169. PubMed ID: 37386469 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R; Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163 [TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Howard JF; Bril V; Vu T; Karam C; Peric S; Margania T; Murai H; Bilinska M; Shakarishvili R; Smilowski M; Guglietta A; Ulrichts P; Vangeneugden T; Utsugisawa K; Verschuuren J; Mantegazza R; Lancet Neurol; 2021 Jul; 20(7):526-536. PubMed ID: 34146511 [TBL] [Abstract][Full Text] [Related]
8. Understanding side effects of therapy for myasthenia gravis and their impact on daily life. Bacci ED; Coyne KS; Poon JL; Harris L; Boscoe AN BMC Neurol; 2019 Dec; 19(1):335. PubMed ID: 31864345 [TBL] [Abstract][Full Text] [Related]
9. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study. Bozovic I; Ilic Zivojinovic J; Peric S; Kostic M; Ivanovic V; Lavrnic D; Basta I J Neurol; 2022 Apr; 269(4):2039-2045. PubMed ID: 34480608 [TBL] [Abstract][Full Text] [Related]
12. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
13. Medical and surgical treatment for ocular myasthenia. Benatar M; Kaminski H Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623 [TBL] [Abstract][Full Text] [Related]